Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pfizer Inc (DE:PFE)
:PFE
PFE Stock Chart & Stats
Day’s Range― - ―
52-Week Range€23.25 - €29.50
Previous CloseN/A
Volume2.00K
Average Volume (3M)61.04K
Market Cap
€137.82B
Enterprise Value€223.98B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)18.7
Beta0.04
Next Earnings
May 06, 2025EPS Estimate
0.68Last Dividend Ex-Date
Jan 24, 2025Dividend Yield6.62%
Share Statistics
EPS (TTM)1.29
Shares Outstanding5,666,990,000
10 Day Avg. Volume83,164
30 Day Avg. Volume61,044
Standard Deviation0.08
R-Squared0.00324
Alpha0.00206
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.41
Price to Cash Flow (P/CF)5.40
P/FCF Ratio5.30
Enterprise Value/Market Cap1.63
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.89
Enterprise Value/Ebitda13.71
Forecast
1Y Price Target
€29.46Price Target Upside20.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
---
Bulls Say, Bears Say
Bulls Say
Debt ManagementPfizer paid down nearly $8B in debt, putting them on track to hit their leverage target by year-end 2025.
Financial PerformancePfizer reported strong results and raised its EPS estimates, reflecting successful performance.
Market OpportunitiesElrexfio presents a multi-billion dollar opportunity in multiple myeloma, with potential to significantly expand treatment options.
Bears Say
Growth UncertaintyProjected long-term EPS growth is negative, indicating a potential decline without new developments.
Market CompetitionThe long-term outlook for many of Pfizer's larger franchises remains uncertain, given upcoming patent expiries and competitive threats.
Product PerformanceA notable miss this quarter came from Abrysvo, which was significantly below expectations, potentially impacted by warmer winter temperatures in the US.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.03% Insiders
18.13% Mutual Funds
9.31% Other Institutional Investors
50.25% Public Companies and Individual Investors
PFE FAQ
What was Pfizer Inc’s price range in the past 12 months?
Pfizer Inc lowest stock price was €23.25 and its highest was €29.50 in the past 12 months.
What is Pfizer Inc’s market cap?
Pfizer Inc’s market cap is €137.82B.
When is Pfizer Inc’s upcoming earnings report date?
Pfizer Inc’s upcoming earnings report date is May 06, 2025 which is in 78 days.
How were Pfizer Inc’s earnings last quarter?
Pfizer Inc released its earnings results on Feb 04, 2025. The company reported €0.602 earnings per share for the quarter, beating the consensus estimate of €0.451 by €0.151.
Is Pfizer Inc overvalued?
According to Wall Street analysts Pfizer Inc’s price is currently Undervalued.
Does Pfizer Inc pay dividends?
Pfizer Inc pays a Quarterly dividend of €1.607 which represents an annual dividend yield of 6.62%. See more information on Pfizer Inc dividends here
What is Pfizer Inc’s EPS estimate?
Pfizer Inc’s EPS estimate is 0.68.
How many shares outstanding does Pfizer Inc have?
Pfizer Inc has 5,666,990,000 shares outstanding.
What happened to Pfizer Inc’s price movement after its last earnings report?
Pfizer Inc reported an EPS of €0.602 in its last earnings report, beating expectations of €0.451. Following the earnings report the stock price went down -2.891%.
Which hedge fund is a major shareholder of Pfizer Inc?
Among the largest hedge funds holding Pfizer Inc’s share is Diamond Hill Capital Management Inc. It holds Pfizer Inc’s shares valued at 479M.
---
Pfizer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€29.46 (20.66% Upside)
€29.46 (20.66% Upside)
Blogger Sentiment
Bullish
DE:PFE Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $499.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 19%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.07%
12-Months-Change
Fundamentals
Return on Equity
4.52%
Trailing 12-Months
Asset Growth
2.07%
Trailing 12-Months
Company Description
Pfizer Inc
Pfizer Inc. develops, manufactures and sells healthcare products, including innovative medicines and vaccines. Its key focus areas include oncology, inflammation & immunology, rare disease, vaccines and internal medicine. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
---
PFE Company Deck
---
PFE Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Pfizer demonstrated strong financial performance and strategic progress in 2024, with significant achievements in market leadership and pipeline advancements. While there are challenges with specific products and external factors such as the IRA, the overall sentiment is positive due to the robust execution and strategic positioning for future growth.Read More>---
PFE Revenue Breakdown
52.29% Primary Care
25.59% Specialty Care
19.88% Oncology
2.24% BUSINESS INNOVATION
---
PFE Stock 12 Month Forecast
Average Price Target
€29.46
▲(20.66% Upside)
Technical Analysis
Bristol-Myers Squibb
―
Eli Lilly & Co
―
Johnson & Johnson
―
Merck & Company
―
AbbVie
―
Best Analysts Covering PFE
1 Year
1 Year Success Rate
26/35 ratings generated profit
1 Year Average Return
+5.41%
reiterated a buy rating 2 months ago
Copying Vamil Divan's trades and holding each position for 1 Year would result in 74.29% of your transactions generating a profit, with an average return of +5.41% per trade.
---